Factors associated with clinically significant nephritis in systemic lupus erythematosus patients who present with glomerular hematuria: a cross-sectional study
Rheumatology International · 07.08.2026 · 46 (8)
DOI: 10.1007/s00296-026-06264-4 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Rheumatology International, online erschienen am 07.08.2026. Verfasst von Konstantinos Drougkas und 12 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology and Clinical Immunology Unit, Medical School, Attikon University Hospital, National and Kapodistrian University of Athens, 1 Rimini Stre…. Hauptthemen laut MEDLINE: Hematuria, Lupus Nephritis, Lupus Erythematosus, Systemic. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Athens.
Abstract (Originalsprache)
EULAR recommends kidney biopsy in systemic lupus erythematosus (SLE) patients with glomerular hematuria, whereas both ACR and KDIGO require the presence of proteinuria and/or impaired kidney function. We explored the value of hematuria for the diagnosis of new-onset lupus nephritis (LN). Cross-sectional study of SLE patients who underwent diagnostic kidney biopsy in two independent centers. Clinically significant LN was defined as ISN/RPS class III, IV, V, or mixed III/IV + V. Presentation patterns were categorized by glomerular hematuria, proteinuria, and impaired kidney function. Among patients with glomerular hematuria, regression models identified factors associated with clinically significant LN, and a nomogram was constructed. Of 227 biopsies, 181 (79.7%) showed clinically significant LN. Isolated glomerular hematuria was evident in 11 patients, of whom 9 revealed non-LN pathology; the two LN cases (class II and III) both demonstrated concurrent SLE serologic activity. Among patients with glomerular hematuria ( n = 137), independent factors associated with clinically significant LN included anti-dsDNA positivity (OR 12.00, 95% CI 3.36–51.40), higher non-renal SLEDAI score (OR 1.20 per point, 95% CI 1.02–1.46), higher proteinuria (OR 3.77 per 1 g/d, 95% CI 2.00–9.03), and younger age (OR 0.96 per year, 95% CI 0.91–1.00). The combined presence of these factors yielded a predicted probability of 97% (95% CI 90–99%) of clinically significant LN, whereas their absence was associated with a probability of only 6% (95% CI 1–23%). When considering the need for kidney biopsy in patients with lupus, hematuria should be evaluated in the context of overall disease activity; extra-renal and serologic activity substantially increase the likelihood of clinically significant LN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rheumatology and Clinical Immunology Unit, Medical School, Attikon University Hospital, National and Kapodistrian University of Athens, 1 Rimini Stree, Athens, 12462, Greece.
- Department of Internal Medicine, Division of Rheumatology, Manisa State Hospital, Manisa, Turkey.
- Department of Internal Medicine, Division of Rheumatology, Izmir Katip Celebi University, Izmir, Turkey.
- Department of Nephrology, 2nd Propaedeutic Internal Medicine, Medical School, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
- First Department of Pathology, Laiko General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
- Rheumatology, Clinical Immunology and Allergy Department, University Hospital of Heraklion, University of Crete, Heraklion, Greece.
Förderung
- University of Athens
Zitieren
APA
Drougkas, K., Otman, E., Katechis, S., Pappa, M., Yogurtcu, O., Flouda, S., Nikolopoulos, P., Lionaki, S., Banos, A., Liapis, G., Bertsias, G., Boumpas, D. T., & Fanouriakis, A. (2026). Factors associated with clinically significant nephritis in systemic lupus erythematosus patients who present with glomerular hematuria: a cross-sectional study. Rheumatology International, 46(8). https://doi.org/10.1007/s00296-026-06264-4
Vancouver
Drougkas K, Otman E, Katechis S, Pappa M, Yogurtcu O, Flouda S, et al. Factors associated with clinically significant nephritis in systemic lupus erythematosus patients who present with glomerular hematuria: a cross-sectional study. Rheumatology International. 2026;46(8). doi:10.1007/s00296-026-06264-4
BibTeX
@article{Drougkas2026,
author = {Drougkas, Konstantinos and Otman, Eda and Katechis, Spyridon and Pappa, Maria and Yogurtcu, Ozge and Flouda, Sofia and Nikolopoulos, Petros and Lionaki, Sophia and Banos, Aggelos and Liapis, George and Bertsias, George and Boumpas, Dimitrios T and Fanouriakis, Antonis},
title = {Factors associated with clinically significant nephritis in systemic lupus erythematosus patients who present with glomerular hematuria: a cross-sectional study},
journal = {Rheumatology International},
year = {2026},
volume = {46},
number = {8},
doi = {10.1007/s00296-026-06264-4}
}
EUVIMED